US President Donald Trump’s announcement of sweeping prescription drug price cuts under a “Most Favoured Nation” policy has put India’s pharmaceutical industry in focus.

Read original article

Tags:
Leave a Comment

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *